Edwards Lifesciences
EW
S$97.83
Share price
-0.30%
Change (1 day)
-21.49%
Change (1 year)
Categories
Edwards Lifesciences (EW) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : S$3.60 Billion
According to Edwards Lifesciences's latest financial reports the company's total liabilities are S$3.60 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Edwards Lifesciences - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | S$4.06 B | 16.49% |
| 2023-12-31 | S$3.49 B | 4.78% |
| 2022-12-31 | S$3.33 B | -7.56% |
| 2021-12-31 | S$3.60 B | 2.34% |
| 2020-12-31 | S$3.52 B | 11.67% |
| 2019-12-31 | S$3.15 B | 5.76% |
| 2018-12-31 | S$2.98 B | -17.72% |
| 2017-12-31 | S$3.62 B | 32.45% |
| 2016-12-31 | S$2.73 B | 24.57% |
| 2015-12-31 | S$2.19 B | 24.87% |
| 2014-12-31 | S$1.75 B | 19.15% |
| 2013-12-31 | S$1.47 B | 62.69% |
| 2012-12-31 | S$0.90 B | 9.06% |
| 2011-12-31 | S$0.83 B | 40.75% |
| 2010-12-31 | S$0.59 B | -7.97% |
| 2009-12-31 | S$0.64 B | -13.84% |
| 2008-12-31 | S$0.74 B | 1.58% |
| 2007-12-31 | S$0.73 B | -3.76% |
| 2006-12-31 | S$0.76 B | -15.03% |
| 2005-12-31 | S$0.89 B | 13.54% |
| 2004-12-31 | S$0.79 B | -0.21% |
| 2003-12-31 | S$0.79 B | -1.81% |
| 2002-12-31 | S$0.80 B | -16.85% |
| 2001-12-31 | S$0.97 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | S$22.54 B | 525.08% | 🇺🇸 USA |
 Merit Medical MMSI | S$1.32 B | -63.28% | 🇺🇸 USA |
 LeMaitre Vascular LMAT | S$0.26 B | -92.64% | 🇺🇸 USA |
 Medtronic MDT | S$51.41 B | 1,325.73% | 🇮🇪 Ireland |
 ICU Medical
ICUI | S$2.79 B | -22.39% | 🇺🇸 USA |